ProcuraAxisBeta
Sign inCreate Free Account
Home / Opportunities / Opportunity
PROCUREMENT OPPORTUNITY

BCG Vaccine & TB Skin Test (2027)

Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · Tender notice on Find a Tender

Tender information last checkedLast checked 2 Oct 2026, 02:31.

Opportunity overview

The provision of Bacillus Calmette-Guérin (BCG) vaccine and intradermal diagnostic skin test for the detection of Mycobacterium tuberculosis infection. Deliveries will be required up to a period of 2 years, with an option to extend for up to an additional 24 months. Information about volumes for each lot is included in the Invitation to Offer documents.

Classification

  • CPV33651600 — Vaccines
  • CPV33694000 — Diagnostic agents

Lots

  • Bacillus Calmette-Guérin (BCG) vaccineValue not stated
  • Intradermal diagnostic skin test for the detection of Mycobacterium tuberculosisValue not stated

Documents and notices

Published notice details

Additional information from the published procurement release. Fields appear only when supplied by the source; check the original notice and tender documents before acting.

Scope, procedure and submissions

Id
C426981
Status
active
Procurement Method
open
Procurement Method Details
Competitive flexible procedure
Main Procurement Category
goods
Above Threshold
Yes
Has Recurrence
Yes
Published risks
The below known unknown risks has been identified, which may require modification of the contract under paragraph 5 of Schedule 8 to the PA 2023 if one of the below identified risks materialise. Risk 1: The COVID-19 pandemic led to lockdown events, which disrupted the distribution and uptake of some national immunisation campaigns. The forecast delivery and stock requirements were substantially changed as a result. An ongoing risk is the materialisation of a UK health emergency or global pandemic, which may materialise in any given year. How the risk may impact on the performance of the contract: A health emergency or pandemic may materially affect the uptake of the product(s). Continued delivery of the product(s) within the original term of the contract could jeopardise stock management and effective use of product before expiry. Why is it not possible to address the potential impact of such risks? UKHSA and suppliers cannot reasonably predict the occurrence of a pandemic. UKHSA cannot determine an effective delivery schedule and contract term which would be effective during a pandemic to mitigate the risk of reduced uptake.

Legal basis

Id
2023/54
Scheme
UKPGA

Procedure

Features
This procurement is conducted in accordance with the Procurement Act 2023 using a competitive flexible procedure. Initial Offers will be evaluated by the Authority against the award criteria set out in the Invitation to Offer. • Lot 1: Offerors for Lot 1 who pass the award criteria will proceed to the negotiation stage if a negotiation stage is required. A negotiation stage will be used for Lot 1 if any elements of the Offer are unclear or do not meet the Specification or otherwise require discussion using the subjects for negotiation set out • Lot 2: Offerors who pass the award criteria outlined will proceed to the negotiation stage for Lot 2. The Authority may choose to negotiate different aspects of the Offers with different Offerors, provided that the Authority does so in a manner consistent with the principles set out in section 12 of the Procurement Act 2023, including the duty to act transparently and to treat suppliers fairly. After the Negotiation Stage has closed, the Authority will invite final Offers in the form of a resubmission. Further information on the negotiation process is described in the tender documentation.

Submission terms

Electronic Submission Policy
allowed

Languages

en

Tender Period

Ends
15 Jun 2026, 13:00

Enquiry period

Ends
1 Jun 2026, 13:00

Expected award period

Ends
20 Oct 2026, 23:59

Recurrence

Dates

Entry 1
Starts
20 Oct 2026, 23:59

Lots and requirements

Entry 1
Id
1
Title
Bacillus Calmette-Guérin (BCG) vaccine
Description
BCG vaccine indicated for the prevention of Tuberculosis
Status
active
Has Renewal
Yes

Value

Including VAT
0
Amount
0
Currency
GBP

Award criteria

Weighting Description
Full details of the award criteria can be found in the tender documentation.

Criteria

Criterion 1
Type
quality
Name
Quality criterion
Description
Comparison with specification
Criterion 2
Type
quality
Name
Quality criterion
Description
Risk to programme delivery
Criterion 3
Type
quality
Name
Quality criterion
Description
Social value
Criterion 4
Type
cost
Name
Cost criterion
Description
Benchmark price
Criterion 5
Type
cost
Name
Cost criterion
Description
Product price
Criterion 6
Type
cost
Name
Cost criterion
Description
Additional costs
Criterion 7
Type
cost
Name
Cost criterion
Description
Storage costs
Criterion 8
Type
quality
Name
Quality critierion
Description
Comparison with specification
Criterion 9
Type
quality
Name
Quality criterion
Description
Risk to programme delivery
Criterion 10
Type
quality
Name
Quality criterion
Description
Social value
Criterion 11
Type
cost
Name
Cost criterion
Description
Benchmark price
Criterion 12
Type
cost
Name
Cost criterion
Description
Product price
Criterion 13
Type
cost
Name
Cost criterion
Description
Additional costs
Criterion 14
Type
cost
Name
Cost criterion
Description
Storage costs

Contract period

Starts
1 Apr 2027, 00:00
Ends
31 Mar 2029, 23:59
Max Extent Date
31 Mar 2031, 23:59

Renewal

Description
There is an option for the Authority to extend for a period or periods up to an additional 24 months
Entry 2
Id
2
Title
Intradermal diagnostic skin test for the detection of Mycobacterium tuberculosis
Description
An intradermal diagnostic skin test, indicated for the detection of Mycobacterium tuberculosis infection
Status
active
Has Renewal
Yes

Value

Including VAT
0
Amount
0
Currency
GBP

Award criteria

Weighting Description
Full details of the award criteria can be found in the tender documentation.

Criteria

Criterion 1
Type
quality
Name
Quality criterion
Description
Comparison with specification
Criterion 2
Type
quality
Name
Quality criterion
Description
Risk to programme delivery
Criterion 3
Type
quality
Name
Quality criterion
Description
Social value
Criterion 4
Type
cost
Name
Cost criterion
Description
Benchmark price
Criterion 5
Type
cost
Name
Cost criterion
Description
Product price
Criterion 6
Type
cost
Name
Cost criterion
Description
Additional costs
Criterion 7
Type
cost
Name
Cost criterion
Description
Storage costs
Criterion 8
Type
quality
Name
Quality critierion
Description
Comparison with specification
Criterion 9
Type
quality
Name
Quality criterion
Description
Risk to programme delivery
Criterion 10
Type
quality
Name
Quality criterion
Description
Social value
Criterion 11
Type
cost
Name
Cost criterion
Description
Benchmark price
Criterion 12
Type
cost
Name
Cost criterion
Description
Product price
Criterion 13
Type
cost
Name
Cost criterion
Description
Additional costs
Criterion 14
Type
cost
Name
Cost criterion
Description
Storage costs

Contract period

Starts
1 Apr 2027, 00:00
Ends
31 Mar 2029, 23:59
Max Extent Date
31 Mar 2031, 23:59

Renewal

Description
There is an option for the Authority to extend for a period or periods up to an additional 24 months

Items and delivery

Item 1
Id
1
Related Lot
1

Additional Classifications

Entry 1
Scheme
CPV
Id
33651600
Description
Vaccines

Delivery locations

Entry 1
Region
UK
Country
GB
Country Name
United Kingdom
Item 2
Id
2
Related Lot
2

Additional Classifications

Entry 1
Scheme
CPV
Id
33694000
Description
Diagnostic agents

Delivery locations

Entry 1
Region
UK
Country
GB
Country Name
United Kingdom

Published documents

Entry 1
Id
conflictOfInterest
Document Type
conflictOfInterest
Entry 2
Id
043013-2026
Document Type
tenderNotice
Notice Type
UK4
Description
Tender notice on Find a Tender
Published
11 May 2026, 13:48
Format
text/html

Buyer, suppliers and contacts

Organisation 1
Name
Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
Id
GB-PPON-PBMQ-7576-DVGW

Identifier

Scheme
GB-PPON
Id
PBMQ-7576-DVGW

Address

Street Address
10 South Colonnade
Locality
London
Postal Code
E14 4PU
Country
GB
Country Name
United Kingdom
Region
UKI42

Contact

Name
VMC Vaccines

Roles

buyer

Details

Classifications

Entry 1
Scheme
UK_CA_TYPE
Id
publicAuthorityCentralGovernment
Description
Public authority - central government

Recorded locations

  • Buyer location · London · UKI42 · E14 4PU · United Kingdom
  • Delivery location · UK · United Kingdom

Notice and amendment history

2 published notice versions reviewed by ProcuraAxis.

2 VERSIONS
  1. 039130-2026Preliminary market engagement notice on Find a Tender ·
  2. 043013-2026Tender notice on Find a Tender ·